Table 3.
S.No | Group (n = 8) | Model induction | Treatment |
---|---|---|---|
I | SC | - | Normal saline |
II | ACSF | ACSF only | Normal saline |
III | COL |
Colchicine 15 µg (ICV) induced dementia (chronic model) |
Normal saline |
IV | COL + ORSM | Rivastigmine (2.5 mg/kg, p.o.) | |
V | COL + INRSM | Rivastigmine (2.0 mg/kg, IN) | |
VI | COL + INRL | Rivastigmine liposomes (2.0 mg/kg, IN) |
SC sham control, ACSF artificial cerebrospinal fluid, COL colchicine, ORSM oral pure rivastigmine, INRSM intranasal pure rivastigmine, INRL intranasal liposomal formulation of rivastigmine